New Owners Take Control of Bryn Inc., Appointing Experienced CEO and CFO
Summary
Bryn Inc., a company facing going concern doubts, announced a change of control with MEDO Healthcare LLC acquiring 84.7% of voting power and appointing a new CEO and CFO with strong financial backgrounds.
Key Events · Corporate Governance and Compliance · BRRN
-
Change of Control
MEDO Healthcare LLC purchased 10 million Series A-1 Preferred Stock shares from Custodian Ventures LLC for $175,000, gaining 84.7% of Bryn Inc.'s total voting power.
-
New Leadership Appointed
David Lazar resigned from all positions, and John Leo was appointed as the new CEO and sole director, with Arthur Magee named CFO and Secretary.
-
Experienced Management Team
The new CEO, John Leo, and CFO, Arthur Magee, bring extensive experience in investment banking, capital markets, M&A, and corporate advisory services, including prior CEO and CFO roles at public companies.
-
Addresses Going Concern Warning
This change of control and capital injection directly addresses the 'going concern' warning from the recent 10-K, offering a path for revitalization for the dormant shell company.
Analysis · BRRN · Trade & Services
This 8-K reports a complete change of control and management for Bryn Inc., a company previously flagged with a going concern warning and zero cash. MEDO Healthcare LLC acquired 84.7% of the voting power for $175,000, replacing the former sole director and officer. The appointment of John Leo as CEO and Arthur Magee as CFO, both with extensive financial and investment banking backgrounds, signals a potential strategic shift and an attempt to revitalize the dormant shell company. This event directly addresses the company's previous financial distress by bringing in new capital and leadership.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.8% of the 328 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRRN was trading at $0.30 on OTC in the Trade & Services sector, with a market capitalization of approximately $126M. The 52-week trading range was $0.00 to $9.90. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.